120 related articles for article (PubMed ID: 25292091)
1. Lack of association between the COMT rs4680 polymorphism and ovarian cancer risk: evidence from a meta-analysis of 3,940 individuals.
Du JZ; Dong YL; Wan GX; Tao L; Lu LX; Li F; Pang LJ; Jia W
Asian Pac J Cancer Prev; 2014; 15(18):7941-5. PubMed ID: 25292091
[TBL] [Abstract][Full Text] [Related]
2. Lack of associations of the COMT Val158Met polymorphism with risk of endometrial and ovarian cancer: a pooled analysis of case-control studies.
Liu JX; Luo RC; Li R; Li X; Guo YW; Ding DP; Chen YZ
Asian Pac J Cancer Prev; 2014; 15(15):6181-6. PubMed ID: 25124595
[TBL] [Abstract][Full Text] [Related]
3. Correlations between the COMT gene rs4680 polymorphism and susceptibility to ovarian cancer.
Pan W; Liao H
Genet Mol Res; 2015 Dec; 14(4):16813-8. PubMed ID: 26681027
[TBL] [Abstract][Full Text] [Related]
4. Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.
Qin X; Peng Q; Qin A; Chen Z; Lin L; Deng Y; Xie L; Xu J; Li H; Li T; Li S; Zhao J
Diagn Pathol; 2012 Oct; 7():136. PubMed ID: 23039364
[TBL] [Abstract][Full Text] [Related]
5. The Catechol-O-Methyltransferase Val158Met Polymorphism Contributes to the Risk of Breast Cancer in the Chinese Population: An Updated Meta-Analysis.
Wan GX; Cao YW; Li WQ; Li YC; Li F
J Breast Cancer; 2014 Jun; 17(2):149-56. PubMed ID: 25013436
[TBL] [Abstract][Full Text] [Related]
6. Associations of endocrine stress-related gene polymorphisms with risk of autism spectrum disorders: Evidence from an integrated meta-analysis.
Yang PY; Menga YJ; Li T; Huang Y
Autism Res; 2017 Nov; 10(11):1722-1736. PubMed ID: 28656683
[TBL] [Abstract][Full Text] [Related]
7. Association between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk.
Tan X; Chen M
Diagn Pathol; 2014 Oct; 9():192. PubMed ID: 25280560
[TBL] [Abstract][Full Text] [Related]
8. Significant Association of the
Huang X; Wang C; Zheng L; Ren L; Jin T; Yu Z; Tang Y
Genet Test Mol Biomarkers; 2022 Jun; 26(6):316-323. PubMed ID: 35763385
[No Abstract] [Full Text] [Related]
9. Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis.
Sadeghiyeh T; Hosseini Biouki F; Mazaheri M; Zare-Shehneh M; Neamatzadeh H; Poursharif Z
J Res Health Sci; 2017 Jun; 17(2):e00383. PubMed ID: 28676589
[TBL] [Abstract][Full Text] [Related]
10. Association between COMT gene Val108/158Met and antidepressive treatment response: A meta-analysis.
Tang Z; Zhang S; Guo D; Wang H
Gene; 2020 Apr; 734():144333. PubMed ID: 31972309
[TBL] [Abstract][Full Text] [Related]
11. The association between COMT Val158Met polymorphism and migraine risk: A meta-analysis.
Liao YJ; Jiang JR; Jin SQ
Cephalalgia; 2017 May; 37(6):592-598. PubMed ID: 27154995
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.
Goodman JE; Lavigne JA; Hengstler JG; Tanner B; Helzlsouer KJ; Yager JD
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1373-6. PubMed ID: 11142424
[TBL] [Abstract][Full Text] [Related]
13. The Role of a Catechol-O-Methyltransferase (COMT) Val158Met Genetic Polymorphism in Schizophrenia: A Systematic Review and Updated Meta-analysis on 32,816 Subjects.
González-Castro TB; Hernández-Díaz Y; Juárez-Rojop IE; López-Narváez ML; Tovilla-Zárate CA; Fresan A
Neuromolecular Med; 2016 Jun; 18(2):216-31. PubMed ID: 27020768
[TBL] [Abstract][Full Text] [Related]
14. No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.
Zou LW; Xu XJ; Liu T; Wang HY; Fan WJ; Wang XH; Zhang ZX; Zhai JX
Genet Test Mol Biomarkers; 2013 Jan; 17(1):78-84. PubMed ID: 23116175
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis reveals a lack of association between a common catechol-O-methyltransferase (COMT) polymorphism val¹⁵⁸met and fibromyalgia.
Zhang L; Zhu J; Chen Y; Zhao J
Int J Clin Exp Pathol; 2014; 7(12):8489-97. PubMed ID: 25674213
[TBL] [Abstract][Full Text] [Related]
16. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
[TBL] [Abstract][Full Text] [Related]
17. Catechol-O-methyltransferase 158G/A polymorphism and endometriosis/adenomyosis susceptibility: A meta-analysis in the Chinese population.
Li YW; Wang CX; Chen JS; Chen L; Zhang XQ; Hu Y; Niu XB; Pei DX; Liu XW; Bi YY
J Cancer Res Ther; 2018 Dec; 14(Supplement):S980-S984. PubMed ID: 30539833
[TBL] [Abstract][Full Text] [Related]
18. COMT gene and risk for Parkinson's disease: a systematic review and meta-analysis.
Jiménez-Jiménez FJ; Alonso-Navarro H; García-Martín E; Agúndez JA
Pharmacogenet Genomics; 2014 Jul; 24(7):331-9. PubMed ID: 24819480
[TBL] [Abstract][Full Text] [Related]
19. Lack of Association between rs4680 Polymorphism in Catechol-O-Methyltransferase Gene and Alcohol Use Disorder: A Meta-Analysis.
Jin XR; Zhao ZQ
Dis Markers; 2020; 2020():8850859. PubMed ID: 33282008
[TBL] [Abstract][Full Text] [Related]
20. Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.
Lin G; Zhao J; Wu J; Andreevich O R; Zhang WH; Zhang Y; Yu L
Genet Mol Res; 2013 Dec; 12(4):6442-53. PubMed ID: 24390993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
